Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.
Baldelli E, Bellezza G, Haura EB, Crinó L, Cress WD, Deng J, Ludovini V, Sidoni A, Schabath MB, Puma F, Vannucci J, Siggillino A, Liotta LA, Petricoin EF 3rd, Pierobon M.
Baldelli E, et al. Among authors: haura eb.
Oncotarget. 2015 Oct 20;6(32):32368-79. doi: 10.18632/oncotarget.5941.
Oncotarget. 2015.
PMID: 26468985
Free PMC article.